Kynam Capital Management, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Kynam Capital Management, LP disclosed 24 US equity positions worth $1.3bn in its Q3 2024 13F filing. The largest position was NTRA at 20.1% of the reported book, followed by PCVX and CLDX.
What did Kynam Capital Management, LP own in Q3 2024? Top 24 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NTRA NATERA INC | Healthcare | 20.1% | $259.3m | 2,042,471 | – | |
| 2 | PCVX VAXCYTE INC | Healthcare | 9.2% | $118.8m | 1,039,288 | – | |
| 3 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 9.1% | $117.6m | 3,458,609 | – | |
| 4 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 8.7% | $112.5m | 5,842,925 | – | |
| 5 | COGT COGENT BIOSCIENCES INC | Healthcare | 7.7% | $99.8m | 9,239,731 | – | |
| 6 | DVAX DYNAVAX TECHNOLOGIES CORP | 7.2% | $92.8m | 8,332,687 | – | ||
| 7 | VERA VERA THERAPEUTICS INC | Healthcare | 5.4% | $69.7m | 1,576,549 | – | |
| 8 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 5.4% | $69.0m | 9,085,368 | – | |
| 9 | CGON CG ONCOLOGY INC | Healthcare | 5.2% | $66.8m | 1,770,805 | – | |
| 10 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 4.4% | $57.1m | 2,511,295 | – | |
| 11 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 3.1% | $40.2m | 4,899,497 | – | |
| 12 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.5% | $31.9m | 1,302,085 | – | |
| 13 | TSVT* 2SEVENTY BIO INC | 2.2% | $28.1m | 5,953,825 | – | ||
| 14 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.8% | $22.7m | 2,266,328 | – | |
| 15 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.6% | $20.5m | 456,369 | – | |
| 16 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.5% | $19.2m | 1,371,511 | – | |
| 17 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.2% | $15.2m | 3,685,563 | – | |
| 18 | ENGENE HOLDINGS INC | 0.9% | $11.5m | 1,736,227 | – | ||
| 19 | TYRA TYRA BIOSCIENCES INC | Healthcare | 0.9% | $11.0m | 467,947 | – | |
| 20 | AMARIN CORP PLC | 0.6% | $7.8m | 12,414,628 | – | ||
| 21 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.6% | $7.1m | 2,066,447 | – | |
| 22 | CRBU CARIBOU BIOSCIENCES INC | Healthcare | 0.4% | $4.6m | 2,356,147 | – | |
| 23 | ACELYRIN INC | 0.3% | $4.2m | 847,366 | – | ||
| 24 | BNR BURNING ROCK BIOTECH LTD | 0.3% | $3.2m | 989,217 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.